Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
10. Dezember 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
[Latest] Global Pharmaceutical Membrane Filtration Market Size/Share Worth USD 27,620 Million by 2033 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
21. November 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Membrane Filtration Market Size, Trends and Insights By Product...
Pacific Genetech Hercules Delivery System Recognized With “Vaccine Innovation Of The Year” By BioTech Breakthrough
19. November 2024 08:01 ET
|
BioTech Breakthrough
FAYETTEVILLE, Ark., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Pacific Genetech today announced that Hercules is the recipient of the “Vaccine Innovation Of The Year” award in the fourth annual BioTech...
Biolojic Design Joins Johnson & Johnson Innovation - JLABS
19. November 2024 08:00 ET
|
Biolojic Design
Biolojic Design expands U.S. presences by becoming a resident company at Johnson & Johnson JLABS DC
Shifts in the Psoriasis Market Suggest Strong Potential for Emerging Oral Therapies
16. Oktober 2024 14:48 ET
|
Spherix Global Insights
EXTON, PA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Biologics have long been the cornerstone of psoriasis (PsO) treatment, valued for their proven efficacy and safety. However, the growing demand for...
Attovia Therapeutics Appoints Chief Financial Officer
15. Oktober 2024 07:30 ET
|
Attovia Therapeutics, Inc.
FREMONT, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics announced the appointment of Steven Chan as Chief Financial Officer. Mr. Chan brings extensive financial strategy and...
CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank
03. Oktober 2024 07:00 ET
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Oct. 03, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Tumor Necrosis Factor Inhibitor Drugs Market to hit USD 50 billion by 2032, says Global Market Insights Inc.
02. Oktober 2024 05:42 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tumor Necrosis Factor Inhibitor Drugs Market size valued at USD 41.3 billion in 2023 and is projected to grow at a CAGR of 2.2% from...
Biopharmaceutical Market Size Projected to Reach USD 17,902.42 Billion by 2032 with 49.60% CAGR – SNS Insider
27. September 2024 09:24 ET
|
SNS Insider pvt ltd
Pune, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical Market Size & Growth Analysis: According to SNS Insider, The Biopharmaceutical Market Size was valued at USD 572.33 Billion in 2023...
Culture Biosciences Appoints Chris Williams as Chief Executive Officer
26. September 2024 12:05 ET
|
Culture Biosciences
South San Francisco, CA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Culture Biosciences, a leader in cloud-connect bioprocess development technologies, is pleased to announce the appointment of Chris...